Howard Matthew A, Neau Steven H, Sack Marvin J
University of Missouri-Kansas City, School of Pharmacy, 5100 Rockhill Road, Kansas City, MO 64110-2499, USA.
Int J Pharm. 2006 Jan 3;307(1):66-76. doi: 10.1016/j.ijpharm.2005.09.021. Epub 2005 Oct 25.
A means to produce extruded-spheronized beads, devoid of microcrystalline cellulose (MCC) and with a high drug load (greater than 80%, w/w), is presented. Immediate release bead product with a high yield (greater than 60% of 1mm diameter beads) and low friability (mass loss less than 4.0%) that were spherical to the naked eye (roundness score less than 1.20) were obtained. The formulation consists only of water-soluble components, taking advantage of the properties of soluble polyethylene oxide (PEO) and methoxypolyethylene glycol (MPEG). This approach incorporates minimal processing aids, with wetted PEO providing the apparent plasticity and cohesiveness, and MPEG550 providing the apparent self-lubricating characteristics necessary for successful extrusion and subsequent spheronization into beads. The success of this approach has important implications in cases where high drug load beads are desired, but where MCC cannot be used due to chemical incompatibility or where complete release cannot be achieved with MCC-containing beads.
本文介绍了一种生产挤出滚圆微丸的方法,该微丸不含微晶纤维素(MCC)且载药量高(大于80%,w/w)。获得了具有高收率(直径1mm微丸收率大于60%)和低脆碎度(质量损失小于4.0%)的速释微丸产品,肉眼观察呈球形(圆度分数小于1.20)。该制剂仅由水溶性成分组成,利用了可溶性聚环氧乙烷(PEO)和甲氧基聚乙二醇(MPEG)的特性。这种方法使用的加工助剂最少,湿润的PEO提供表观可塑性和内聚性,MPEG550提供成功挤出并随后滚圆成微丸所需的表观自润滑特性。在需要高载药量微丸,但由于化学不相容性不能使用MCC或含MCC的微丸无法实现完全释放的情况下,这种方法的成功具有重要意义。